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Introduction: Hypertension is associated with microcirculatory disturbance, and erythrocyte deformability is a
major determinant of the microcirculation. However, impairment of erythrocyte deformability in hypertensive
patients in relation to antihypertensive treatment is unclear. The present study aimed to investigate this impairment
in hypertensive patients under treatment using a highly sensitive and quantitative nickel mesh filtration technique.
Methods: Deformability was evaluated by filterability, defined as the flow rate of a hematocrit-adjusted erythrocyte
suspension relative to that of saline under a specific filtration pressure in a pressure-flow curve obtained by continuous
filtration. Baseline characteristics of hypertensive patients (n = 101) and age-matched normotensive subjects (n = 14)
were obtained from medical records, and diabetic patients were excluded.
Results: Erythrocyte deformability in the hypertensive group was significantly (p = 0.010) lower (87.8 ± 2.2 %) than that
of the normotensive group (89.4 ± 1.7 %) and inversely proportional (r = −0.303, p = 0.002) to the mean blood pressure
(BP) measured on blood sampling for the filtration study. Stepwise multiple regression analysis demonstrated that this
impairment was mostly attributable to the mean BP (p = 0.001), whereas current smoking and episodes of stroke or
coronary artery disease were not contributors.
Discussion: These findings indicate that erythrocyte deformability is impaired in the hypertensive patients, which
depends on the current BP control rather than target organ damage.
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Hypertension is a very common health-care problem in
adult and elderly populations, and hypertensive complica-
tions such as stroke and coronary artery disease greatly in-
crease medical expenditure [1]. Hypertension has rheologic
impacts on circulating erythrocytes, and an abnormal
erythrocyte rheology sustains a high blood pressure
(BP) [2]. Oxidant stress accompanying this common
disease disrupts the structure and function of oxygen-
carrying human erythrocytes. Endothelial dysfunction
in hypertensive patients also causes the mechanical and
rheologic damage of erythrocytes. Although erythrocyte
abnormalities in hypertensive patients have been widely* Correspondence: maruyama@artsci.kyushu-u.ac.jp
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creativecommons.org/publicdomain/zero/1.0/reported [3, 4], studies focusing on erythrocyte deform-
ability in relation to BP control are limited, i.e., optimal
BP control from the viewpoint of erythrocyte rheology
is a unique antihypertensive strategy to prevent target
organ damage.
The deformability of erythrocytes passing through the
microvascular network is an essential factor affecting
microcirculation. However, the concept of erythrocyte
deformability has not been strictly defined as a physical
quantity, i.e., the evaluation of deformability depends on
the relative sensitivity of the measurement technique.
Since in vivo erythrocyte deformation involves bending,
deformability is quantified by filterability, using a highly
sensitive and quantitative nickel mesh filtration technique
[5–7]. Therefore, we aimed to investigate the rheologic
effects of hypertension on circulating erythrocyte deform-
ability using this filtration technique.article distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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Study population
This was a single-center, case-control study performed
according to the Declaration of Helsinki (2008), i.e.,
signed informed consent was obtained from each subject
prior to enrollment in the study. The study population
consisted of 101 Japanese hypertensive patients and 14
age-matched normotensive subjects. All hypertensive pa-
tients were treated with antihypertensive drugs including
Ca antagonists (65 %), angiotensin receptor blocking
agents (40 %), angiotensin-converting enzyme inhibitors
(17 %), and β-blocking agents (28 %), although combined
antihypertensive drug prescription was common (36 %).
These prescriptions were under the discretion of the
treating physicians in outpatient clinics of the Fukuoka
Seishukai Hospitals in the vicinity of Fukuoka City, Japan.
Blood and urine examination, electrocardiography (ECG),
echocardiography, and chest X-ray were routinely per-
formed during regular monthly visits. Brain CT imaging
and ambulatory ECG were conducted in 76 and 83 % of
the hypertensive patients, respectively. Target organ
damage in the hypertensive group was estimated by our
colleagues in a blind manner. Lifestyle including smoking
and drug prescription in each individual were evaluated by
checking medical records. The normotensive group con-
tained subjects visiting the outpatient clinic of this hospital
once a year for health checkup. The body mass index
(BMI) was calculated by the body weight (kg) divided
by the square of the height (m2).
Atrial fibrillation (AF) was checked by standard and
ambulatory ECG, and so was stroke by brain CT. Coron-
ary artery disease (CAD) included a history of myocardial
infarction, previous percutaneous coronary intervention
(PCI), or coronary artery bypass grafting (CABG). The
brachial BP was measured by the treating physicians
on the morning of regular monthly visits, using a mer-
cury sphygmomanometer in a sitting position after tak-
ing a few minutes rest. The systolic BP (SBP) and
diastolic BP (DBP), measured on the day of blood sam-
pling for erythrocyte deformability estimation, were used
for statistical analysis. The mean BP was calculated as
DBP + (SBP −DBP)/3. Exclusion criteria included diabetic
patients showing HbA1c (National Glycohemoglobin
Standardization Program (NGSP)) of more than 6.5 %
or being prescribed antidiabetic agents, patients with
hemodialysis and dementia, and those with prosthetic
heart valve replacement. The study design was ap-
proved by the internal ethics committee of the Institute
of Rheological Function of Foods, Co., Ltd. (Hisayama,
Fukuoka, Japan).
Erythrocyte suspensions
Erythrocyte suspensions were prepared as described
elsewhere [8, 9]. About 10 mL of venous blood wassampled from the antecubital vein of subjects after
overnight fasting using 21-gauge needles and disposable
syringes (Terumo Japan, Tokyo, Japan) filled with 1/10
volume of 3.8 % trisodium citrate as an anticoagulant.
Blood cell counting and hematocrit measurements were
performed using a hemocytometer (Ace Counter, FLC-
240A, Fukuda Denshi Co., Ltd., Tokyo, Japan). After
centrifugation at 1300×g for 10 min, the supernatant
was carefully aspirated to replace the buffy coat and
plasma with saline buffered with N-(2-hydroxyethyl)-
piperazine-N′-2-ethanesulfonic acid (HEPES) sodium
salt (HEPES-Na). The composition of HEPES-Na-buffered
saline (HBS) was NaCl 141 mM and HEPES-Na 10 mM.
The osmolality and pH of the HBS were 287 mOsm/
kg·H2O and 7.4, respectively. The osmolality of the HBS
was measured using a freezing point depression-type os-
mometer (Fiske Mark 3 Osmometer, Fiske Associates,
MA, USA). Intact erythrocytes were then washed three
times by repeated resuspension with HBS and centrifuga-
tion at 800×g, 600×g, and 500×g for 10 min, respectively.
The final hematocrit of the erythrocyte suspension was ad-
justed to 3.0 %. These procedures were performed within
2 h after blood sampling for a subsequent filtration study.
Nickel mesh filter
Figure 1a shows an electron microscopic photograph of
a nickel mesh filter that was produced in accordance
with our specifications by a photofabrication technique
(Dainippon Printing Co., Ltd., Tokyo, Japan). We speci-
fied that this filter should have an outer diameter of
13 mm, have a filtration area of 8 mm in diameter, be
11-μm thick, and have an interpore distance of 35 μm
(Tsukasa Sokken Co., Ltd., Tokyo, Japan). The vertical
and cylindrical pores were distributed regularly across
the filter without coincidence or branching. The pore
entrances exhibited round and smooth transition into
the pore interior. Pore diameters are all exactly identical
in a specific nickel mesh filter. Filters with a specific
pore diameter ranging from 3.0 to 6.0 μm are available
for selection depending on the suspension materials. After
repeated preliminary experiments to choose an appropri-
ate pore size, a nickel mesh filter with a pore diameter of
4.94 μm was used.
Erythrocyte filterability
A filtration study was performed blindly using a nickel
mesh filtration apparatus (Model NOBU-II, Tsukasa
Sokken Co., Ltd., Tokyo, Japan), as shown in Fig. 1b.
In brief, the relation between hydrostatic pressure (P;
mmH2O) and time (t; second) was obtained during
continuous filtration using a pressure transducer. P
was transformed to the height of a meniscus in a vertical
tube (h; mm). The tangent of the h-t curve determined by
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Fig. 1 a Scanning electron microscopic photograph of a nickel mesh filter. Magnification of a single pore in the nickel mesh shows the smooth
transition into the pore interior (inset). b Schematic illustration of the nickel mesh filtration system. The two equations indicate how to calculate
the relationship between the flow rate (Q) and filtration pressure (P). The height of the meniscus (h) within the vertical tube was obtained by the
continuous reduction of P during the filtration, specific gravity of the specimens within the tube (ρ), and acceleration of gravity (g). Q was calculated
automatically by the first time derivative of h (dh/dt) and internal cross-sectional area of the tube (D, internal diameter of the vertical tube).
The obtained P-Q relationship is displayed on the computer screen
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multiplying the rate of fall by the internal cross-sectional
area of the vertical tube, the relation of flow rates (Q; mL/
min) and corresponding P (P-Q curve) was obtained, which
is a basic of hemodynamics [10, 11]. This procedure was
automatically performed by measurement software installed
on a personal computer (DELL Latitude CS, Dell Inc.,
Round Rock, TX, USA) and monitored on the main win-
dow of the computer screen. Together with the start of data
acquisition, the measurement software displays the h-t
curve continuously during the filtration process. When the
filtration has been completed, the software displays the P-Q
curve. The h-t and P-Q curves are stored simultaneously in
Microsoft Office Excel 2003 on Windows XP (Microsoft,
Tokyo, Japan). The temperature of the specimens was kept
at 25 °C by circulating isothermal water through a water
jacket surrounding the vertical tube (Fig. 1b). The flow rate
of the erythrocyte suspension as a percentage of that of
HBS at 100 mmH2O was used as an index of erythrocyte
deformability. These experiments were performed at room
temperature (22 ± 3 °C).Erythrocyte shape
An aliquot of the erythrocyte suspension was fixed with
an isotonic 1.0 % glutaraldehyde solution containing
24.5 mM NaCl and 50 mM phosphate buffer (pH 7.4).
The shape of erythrocytes was observed blindly by collabo-
rators using a differential interference contrast microscope
(Diaphoto 300, Nikon Co., Ltd., Tokyo, Japan) at ×400
magnification.Data analyses
All data are expressed as means ± SD. For statistical ana-
lyses, a sample size was chosen that provides 90 % power
with an α error of 0.05 based on our previous study [12],
being ≥82 cases. The Kolmogorov-Smirnov test was used
for normality. Comparison of normally distributed con-
tinuous variables between the two groups was conducted
with the unpaired Student’s t test, and that of other vari-
ables was performed by the Mann-Whitney U test. Step-
wise multiple regression analysis was used to determine
the significant contributors to erythrocyte deformability
impairment. None of the variables with missing data
qualified. The criterion for entering into the regression
model was a significant correlation coefficient or other-
wise clinically meaningful variables. Multi-collinearity was
considered to be a variance inflation factor of more than
10. Multiple comparison among tertile subgroups in the
hypertensive patients was performed using the Kruskal-
Wallis test. These analyses were performed using PASW
software (Windows version 18.0; SPSS, Chicago, IL, USA).
Differences with p < 0.05 were considered significant.
Results
Patient profiles
Baseline characteristics of the hypertensive and age-
matched normotensive groups are detailed in Table 1.
Silent stroke (lacunar infarction) was found in 12 pa-
tients, and 15 patients with CAD were included in the
hypertensive group. The prevalence of obesity, defined as
BMI of more than 25 kg/m2 (32.7 vs. 28.6 %, p = 0.704),
and that of current smokers (p = 0.754) were equivalent
Table 1 Baseline characteristics of the hypertensive and normotensive groups
Hypertensive group (n = 101) Normotensive group (n = 14) p value
Age (years) 66.6 ± 10.7 64.2 ± 4.4 0.421
Gender (female/male) 41 / 60 6 / 8 0.872
BMI (kg/m2) 23.5 ± 3.0 22.6 ± 3.4 0.258
Current smoker (%) 29 (28.7) 3 (21.4) 0.754
HbA1c (NGSP) (%) 5.2 ± 0.5 5.2 ± 0.3 0.547
Total cholesterol (mg/dL) 203.2 ± 36.8 202.1 ± 35.5 0.918
HDL cholesterol (mg/dL) 58.2 ± 15.1 62.0 ± 11.5 0.364
LDL cholesterol (mg/dL) 111.1 ± 29.6 125.1 ± 34.3 0.105
Triglyceride (mg/dL) 139.7 ± 100.7 110.7 ± 72.0 0.301
Systolic BP (mmHg) 143.2 ± 18.9 125.1 ± 15.5 <0.001
Diastolic BP (mmHg) 81.0 ± 11.3 72.0 ± 3.3 0.004
Hb (g/dL) 14.0 ± 1.8 13.4 ± 1.1 0.189
Ht (%) 40.4 ± 4.5 38.7 ± 2.9 0.184
MCV (fl) 93.8 ± 4.7 91.7 ± 3.8 0.110
MCH (pg) 32.6 ± 1.9 34.6 ± 0.8 0.651
MCHC (g/dL) 34.7 ± 1.0 31.7 ± 1.5 0.109
Erythrocyte filterability (%) 87.8 ± 2.2 89.4 ± 1.7 0.010
BMI body mass index calculated by body weight (kg) divided by square of height (m2), BP blood pressure, Hb hemoglobin, HbA1c(NGSP) hemoglobin A1c






















Fig. 2 Representative relationships between filtration pressure
(P; mmH2O) and flow rate (Q; mL/min) during the continuous filtration
experiment using erythrocyte suspensions and HEPES-buffered saline.
The P-Q relationships correspond to saline passages (empty square),
filtrations of erythrocyte suspension obtained from the hypertensive
patients (empty triangle), and those of the age-matched normotensive
subjects (empty circle), respectively. P-Q curves in control saline were
completely superimposable, indicating reproducibility. Flow rates in the
hypertensive group were lower than those in the normotensive group
at any given filtration pressure
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HbA1c (NGSP) or the serum lipid profile were found
between the two groups. Hematology showed equivalent
erythrocyte properties.
Erythrocyte filterability
Figure 2 shows representative P-Q curves for saline and
erythrocyte suspensions obtained from the hypertensive
and normotensive patients under the continuous filtra-
tion process. Saline behaved as Newtonian fluid, showing
a linear P-Q relationship passing through the origin. The
linearity was superimposable, indicating the excellent
reproducibility of this filtration system. In contrast, the
P-Q relationships for the erythrocyte suspensions displayed
smooth convex curves along the abscissa over the low-
pressure region, showing non-Newtonian behaviors. This
trend was evident in the hypertensive group compared with
the normotensive group, i.e., the flow rate of the erythro-
cyte suspension of the hypertensive patients was always
lower than that of the normotensive subjects at any given
filtration pressure.
Correlation between BP and filterability
The mean erythrocyte deformability in the hypertensive
patients (87.8 ± 2.2 %, n = 101) was slightly but signifi-
cantly (p = 0.010) impaired relative to that in the age-
matched normotensive subjects (89.4 ± 1.7 %, n = 14,
Table 1). Table 2 summarizes the correlation between
the erythrocyte deformability and demographic variables
Table 2 Correlation of erythrocyte filterability and demographic
variables in the hypertensive patients
Continuous parameters Correlation coefficient p value
BMI (kg/m2) 0.161 0.109
HbA1c (NGSP) (%) 0.140 0.163
Total cholesterol (mg/dL) 0.076 0.450
Mean BP (mmHg) −0.303 0.002
Discrete parameters n p value
Atrial fibrillation 11 0.060
Current smoker 29 0.864
Stroke episode 12 0.211
Coronary artery disease 15 0.821
Abbreviations are shown in Table 1
Table 3 Multiple regression analysis predicting contributors to
erythrocyte filterability
Covariate Variance inflation factor t value p value
BMI (kg/m2) 1.001 1.503 0.136
HbA1c (NGSP) (%) 1.017 0.401 0.689
Total cholesterol (mg/dL) 1.006 1.499 0.137
Mean BP (mmHg) 1.000 −3.431 0.001
Atrial fibrillation 1.044 1.143 0.256
Stroke episode 1.004 −1.498 0.137
Abbreviations are shown in Table 1
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covariates of hypertension or contributors to erythrocyte
deformability in our recent studies [8, 9, 12]. The associa-
tions of erythrocyte deformability with the mean BP alone
was significant (r = −0.303, p = 0.002), yielding the re-
gression line of deformability as a function of the mean
BP, as in y = −0.056x + 93.54 (Fig. 3). The difference of
deformability with respect to AF did not reach signifi-
cance (p = 0.060).
Since hypertension is associated with various covariates,
stepwise multiple regression analysis was performed to
identify significant contributors to impaired erythrocyte
deformability. A clinically relevant regression model in-
cluding covariates of hypertension showed a significant
multiple correlation coefficient (R = 0.327, p = 0.001). In
this model, the mean BP (p = 0.001) alone was a significant
variable contributing independently to the impaired
deformability (Table 3). Although BMI was positively
correlated with serum total cholesterol (r = 0.223, p = 0.025)
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Fig. 3 Individual erythrocyte deformability (%) is plotted as a function
of the corresponding mean blood pressure (BP; mmHg) in the
hypertensive patients (n = 101). Erythrocyte deformability is
inversely proportional to the mean BP (r = −0.303, p = 0.002),
showing a regression line of y = −0.056x + 93.54considering the variance inflation factors (≈1.0). The mean
erythrocyte deformability was compared among the tertiles
of the hypertensive groups divided by the BP control state.
The difference in erythrocyte deformability was significant
(p = 0.009), i.e., the deformability was higher according to
the tertiles showing lower SBP and DBP (Table 4). The
deformability of the tertile showing the lowest BP in the
hypertensive patients (88.6 ± 2.1 %) was not different from
that of the normotensive subjects (89.4 ± 1.7 %, p = 0.185).
Moreover, BP in this tertile was equivalent to that in
the normotensive group (p = 0.467 in SBP, and p = 0.173
in DBP).
Erythrocyte shape
Morphologically, erythrocytes obtained from the hyperten-




The main findings of this study using the sensitive, re-
producible, and quantitative nickel mesh filtration tech-
nique (Fig. 1) are that erythrocyte deformability was
impaired in patients with hypertension even under
treatment (Table 1) and that this impairment was in-
versely proportional to the mean BP (Table 2). Because
a temporary high BP alone was a significant contributor
to the corresponding erythrocyte deformability (Table 3),
this study indicates that intensive BP control should
be recommended to resolve the impaired erythrocyte
deformability and microcirculatory disturbance in the
hypertensive patients (Table 4). Multiple regression ana-
lysis was able to determine contributors to the impairedTable 4 Tertile comparison of erythrocyte filterability among
the hypertensive patients
Tertile Systolic BP Diastolic BP Erythrocyte filterability p value
(n) (mmHg) (mmHg) (%)
First (34) 160.7 ± 12.3 92.9 ± 6.9 87.0 ± 2.1
Second (34) 145.3 ± 9.4 79.7 ± 6.3 87.9 ± 2.3 0.009
Third (33) 122.4 ± 9.6 69.8 ± 5.5 88.6 ± 2.1
Odashiro et al. Clinical Hypertension  (2015) 21:17 Page 6 of 8erythrocyte deformability when this rheologic parameter
was obtained with a highly sensitive and reproducible
filtration technique.
Hypertension and hemorheology
Clinical hypertension usually contains covariates such as
obesity, diabetes, and dyslipidemia, which may influence
intact erythrocyte deformability. Actually, our previous
studies using the same technique as in this study dem-
onstrated that these covariates have a potential impact
on deformability [8, 9, 12]. Therefore, the present study
excluded diabetic patients. The serum lipid profile in the
hypertensive group did not differ from that of the normo-
tensive group, and BMI in the two groups was equivalent
(Table 1).
Intact erythrocyte deformability in the hypertensive
group (87.8 ± 2.2 %, n = 101) was slightly but significantly
(p = 0.010) reduced compared with that in the age-
matched normotensive group (89.4 ± 1.7 %, n = 14, Table 1).
The difference in the mean erythrocyte deformability
between the two groups may be small (Fig. 2). However,
flow-pressure curves of control saline were superimpos-
able (100 % as a positive control), and the deformability of
human erythrocytes subjected to the acute oxidant stress
in vitro was impaired to nearly 0 % (negative control),
which means that the nickel mesh pores were completely
clogged by oxidatively damaged erythrocytes [13]. Consid-
ering these positive and negative controls, it is conceivable
that the level of impaired erythrocyte deformability ob-
served in this study may have a potential rheologic impact
on the microcirculation in vivo.
It is generally accepted that erythrocyte deformability
is mainly determined by (1) the erythrocyte membrane
structure and properties, (2) the internal viscosity that is
reflected by mean corpuscular hemoglobin concentration
MCHC, and (3) the cellular size and other geometric fac-
tors reflected by mean corpuscular volume (MCV) and
the erythrocyte shape [6, 10, 11, 14]. Therefore, abnormal
membrane properties, increases in MCHC or MCV, and
several kinds of shape change impair the erythrocyte
deformability individually or in concert. Considering that
there were no discernible shape changes and there were
equivalent MCV and MCHC in the two groups (Table 1),
the impairment of erythrocyte deformability in the hyper-
tensive group mainly arises from erythrocyte membrane
properties.
Abnormal erythrocyte membrane properties and func-
tions have been reported by extensive laboratory investi-
gations [2–4]. Although further studies are required
concerning whether these membrane abnormalities are
genetic or environmental in hypertensive patients, it is
likely that they are based mostly on the oxidative stress
caused by the systemic or local production of reactive oxy-
gen species (ROS) reported in experimental and clinicalhypertension [15, 16]. Human erythrocytes are so sensitive
to oxidative stress [17, 18] that hypertensive erythrocytes
demonstrate membrane lipid peroxidation and reduced
antioxidative enzyme activities [4]. An impaired redox bal-
ance of hypertensive erythrocytes reduces the membrane
fluidity which is closely associated not only with deform-
ability but also with transmembrane ion transport,
cytosolic Ca2+ handling, and internal pH regulation [19].
Hypertensive erythrocyte membrane abnormalities are
also based on the mechanical stress accompanying vaso-
constriction derived from vascular endothelial dysfunction
[20]. In our recent study of spontaneously hypertensive rats
(SHR), impaired erythrocyte deformability was marked in
the pre-hypertensive stage relative to the established hyper-
tensive stage, suggesting that this rheologic abnormality
may be a prerequisite of hypertension development [21].
Impaired erythrocyte passage in the microvasculature
causes mechanical damage to the stagnant erythrocyte
membrane, insufficient oxygen delivery, and tissue hyp-
oxia, leading to further vasoconstriction and BP elevation
[2]. This vicious rheologic cycle underlies hypertension de-
velopment. The human erythrocyte lifespan is about
120 days, and this filtration technique confirmed that the
mechanical impairment of human erythrocyte deformabil-
ity in vitro is reversible [7]. Therefore, the present study
revealed that the deformability is mostly linked to tempor-
ary BP elevation (Table 3), and the fact that inadequate BP
control cannot reverse the impaired deformability (Table 4)
is compatible with this vicious rheologic cycle theory.
Clinical perspectives
There is a large body of evidence that strict BP control
is required in the hypertensive patients to prevent target
organ damage, whereas evidence that impaired erythrocyte
deformability is associated with poor outcome in the
hypertensive patients is scanty. Fornal et al. reported
the significant correlation between the erythrocyte deform-
ability and the left ventricular (LV) geometry calculated by
LV mass index, i.e., showing that LV mass index increases
with impaired deformability which elevates arterial re-
sistance and cardiac afterload [22]. Considering that LV
hypertrophy (LVH) is a predictor of cardiac mortality
and morbidity, rheologic abnormalities has potential
impact on outcome in the hypertensive patients.
In the Candesartan Antihypertensive Survival Evaluation
in Japan (CASE-J) trial, the risk of cardiac events in the
hypertensive patients showing LVH was reduced and
equivalent to that of those without LVH when strict BP
control (SBP less than 130 mmHg and DBP ranging
from 75 to 79 mmHg) was achieved [23]. Target organ
damage in the hypertensive patients per se is promoted
by oxidant stress and procoagulant, proinflammatory
effects mediated partly by the angiotensin type 1 (AT1)
receptor via the toll-like receptor (TLR) [24]. These
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age, and impaired microcirculation accelerates hypertensive
complications. Actually, strict (SBP less than 130 mmHg)
and not lenient (SBP less than 140 mmHg) BP control has
been reported to suppress the innate immune response,
leading to an inflammatory process via TLR of peripheral
monocytes in the nondiabetic hypertensive subjects, as in
this study [25]. The results of our study are consistent with
these findings in terms of strict BP control resolving
the impaired erythrocyte deformability and microvascular
obstruction in the nondiabetic hypertensive patients.
Limitations
This study has a few limitations. This single-center, cross-
sectional study clarified the BP-dependent alteration of
erythrocyte deformability in the hypertensive patients
(Table 4). However, a longitudinal study is important to
confirm this phenomenon. Moreover, antihypertensive
treatment depended on the discretion of the treating
physicians and was not randomized. Individual antihy-
pertensive drug’s effects on the deformability were not
investigated, because combined antihypertensive drug
prescription was common. Considering that temporary
BP elevation alone was a contributor to the deformability
(Table 3), vascular tonus regulating flow resistance rather
than neuro-humoral factors modified by antihypertensive
drugs may have played a major role in the erythrocyte
rheology.
Conclusion
The present study, using a nickel mesh filtration tech-
nique, clarified that erythrocyte deformability based on
the pressure-flow curve in a filtration study is significantly
impaired in the nondiabetic hypertensive patients even
under treatment. Multiple regression analysis demonstrated
that the level of this impairment depends on temporary
BP control and not on the history of hypertensive com-
plications such as stroke or myocardial infarction. Al-
though a large cohort is required, this study suggests
that optimal antihypertensive treatment is required to
maintain circulating erythrocyte deformability, facilitating
efficient microcirculation.
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